Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study
Year: 2017
Type: article
Source: Gynecologic Oncology
Authors: Phuong L Mai, Marion Piedmonte, Paul K Han, Richard P Moser, Joan L Walker, Gustavo Rodriguez, John Boggess, Thomas J Rutherford, Oliver Zivanovic, David E. Cohn, J Tate Thigpen, Robert M Wenham, Michael L Friedlander, Chad A Hamilton, Jamie Bakkum-Gamez, Alexander B Olawaiye, Martee L Hensley, Mark H Greene, Helen Q Huang, Lari Wenzel
Institutions: National Cancer Institute, Division of Cancer Epidemiology and Genetics, Roswell Park Comprehensive Cancer Center, NRG Oncology, Maine Medical Center Research Institute, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Endeavor Health, University of North Carolina at Chapel Hill, Yale University, Memorial Sloan Kettering Cancer Center, The Ohio State University Wexner Medical Center, The Ohio State University, University of Mississippi Medical Center, Moffitt Cancer Center, Prince of Wales Hospital, Walter Reed National Military Medical Center, Mayo Clinic, University of Pittsburgh, UPMC Health System, Magee-Womens Hospital, University of Pittsburgh Medical Center, Weill Cornell Medicine, University of California, Irvine
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Funders: Yale University, Memorial Sloan-Kettering Cancer Center, Wake Forest University, University of Minnesota, Cleveland Clinic, Cleveland Clinic Foundation, University of Pittsburgh, University of Oklahoma, University of Cincinnati, Case Western Reserve University, Thomas Jefferson University, NRG Oncology, National Institutes of Health, University of Texas MD Anderson Cancer Center, Medical Center, University of Pittsburgh, School of Medicine, Indiana University, National Cancer Institute, National Center for Advancing Translational Sciences, School of Medicine, University of North Carolina at Chapel Hill, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Awards: G1044130170, G1291646684, G1950154987, G359183106, G4054617085, NRG Oncology Network Group Operations Center, G434901823, G5256243594, G5996839100, G70736214, G8494369300, G8526228613, G9000308649, Cancer Center Support Grant, Cancer Center Support Grant, Yale Clinical and Translational Science Award, NRG Oncology - Statistical and Data Management Center
OpenAlex ID: W2586145437